ShadowBuys

Lobbying disclosures · Lobbying report

AMGN: second_quarter 2026 lobbying report

Monitor healthcare regulations and statutes and educate members of Congress on issues with regard to client's interests

Follow AMGN
Became public
Jun 12, 2026, 5:07 PM EDT
Event / period date
Not stated
Collected
Nov 8, 2026, 11:40 AM EST

Why this is connected

Exact legal-name match: AMGEN INC (https://www.sec.gov/Archives/edgar/data/318154/).

Reported lobbying amounts

Income: $5,000.00

These are different reporting measures. They are not added together or treated as spending on one particular bill.

Source evidence

Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/e12fd6f1-b901-4eec-8c97-83c372639e15/","filing_uuid":"e12fd6f1-b901-4eec-8c97-83c372639e15","filing_type":"2T","filing_type_display":"2nd Quarter - Termination","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/e12fd6f1-b901-4eec-8c97-83c372639e15/print/","filing_document_content_type":"text/html","income":"5000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Michael Lamoureux","dt_posted":"2026-06-12T17:07:58-04:00","termination_date":"2026-06-12","registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"611 Pecan Street","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Texarkana","registrant_state":"AR","registrant_zip":"71854","registrant":{"id":401104385,"url":"https://lda.gov/api/v1/registrants/401104385/","house_registrant_id":43581,"name":"WASHINGTON ADVOCACY GROUP","description":"Consulting and government relations","address_1":"611 Pecan Street","address_2":null,"address_3":null,"address_4":null,"city":"Texarkansa","state":"AR","state_display":"Arkansas","zip":"71854","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MICHAEL LAMOUREUX","contact_telephone":"+1 479-886-2277","dt_updated":"2026-07-27T12:37:36.397838-04:00"},"client":{"id":59026,"url":"https://lda.gov/api/v1/clients/59026/","client_id":59026,"name":"AMGEN INC.","general_description":"Biotechnology","client_government_entity":null,"client_self_select":false,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2024-03-04"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Monitor healthcare regulations and statutes and educate members of Congress on issues with regard to client's interests","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":65576,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"LAMOUREUX","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}

Congressional trading in AMGN

These disclosures provide context. Their presence does not establish a link between a trader and the event.

Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.